Eli Lilly

reshuffle pipeline target reorganize shift change
Biotech

Lilly shakes up pain pipeline as part of quarterly R&D clearout

Lilly is pivoting its pain pipeline, punting a midstage program it licensed from Centrexion while adding a candidate from its recent SiteOne buyout.
Nick Paul Taylor Aug 7, 2025 8:28am
Yellow tape measure with a variety of weight loss medication on blue background

Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial

Aug 7, 2025 6:30am
Open farm gate leading into agricultural landscape

Lilly links up with Gate in $856M biobucks deal

Jul 24, 2025 2:32pm
obesity overweight weight loss weigh

Scholar Rock's SMA drug helps Zepbound patients retain muscle

Jun 18, 2025 9:10am
Eli Lilly

Eli Lilly pays $1B upfront to buy gene editing partner Verve

Jun 17, 2025 4:35am
weight loss scale weigh measure tape obesity overweight

Lilly's amylin data impress with 11% weight loss, tolerability

Jun 16, 2025 4:55am